Bruker Overview

  • Year Founded
  • 1960

Year Founded

  • Status
  • Public

  • Employees
  • 11,085

Employees

  • Stock Symbol
  • BRKR

Stock Symbol

  • Investments
  • 113

  • Share Price
  • $56.47
  • (As of Friday Closing)

Bruker General Information

Description

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Contact Information

Website
www.bruker.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 40 Manning Road
  • Billerica, MA 01821
  • United States
+1 (978)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Corporate Office
  • 40 Manning Road
  • Billerica, MA 01821
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bruker Stock Performance

As of 20-Nov-2026, Bruker’s stock price is $56.47. Its current market cap is $8.62B with 153M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$56.47 $62.10 $32.37 - $68.98 $8.62B 153M 2.33M -$1.10

Bruker Financials Summary

As of 30-Sep-2026, Bruker has a trailing 12-month revenue of $3.51B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 11,521,966 8,933,847 11,192,489 11,061,856
Revenue 3,513,100 3,436,500 3,366,400 2,964,500
EBITDA 185,700 287,800 429,300 668,000
Net Income (123,400) (8,600) 113,100 427,200
Total Assets 5,828,300 6,241,400 5,806,700 4,249,900
Total Debt 1,713,400 2,042,900 2,245,300 1,379,600
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bruker Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bruker‘s full profile, request access.

Request a free trial

Bruker Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets
Diagnostic Equipment
Billerica, MA
11,085 As of 2025

Waltham, MA
 

Goettingen, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bruker Competitors (14)

One of Bruker’s 14 competitors is Revvity, a Corporation company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Revvity Corporation Waltham, MA
Sartorius Corporation Goettingen, Germany
Sagence Technologies Corporation Calgary, Canada
GE HealthCare Technologies Corporation Chicago, IL
BioMérieux Formerly PE-Backed Marcy-l'Etoile, France
You’re viewing 5 of 14 competitors. Get the full list »

Bruker Patents

Bruker Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-202025105706-U1 Microfluidic system for microfluidic flow cells Active 23-Sep-2025
DE-102025135265-B3 Device and method for providing laser radiation in the form of a series of successive pulses Active 03-Sep-2025
EP-4838373-A1 Method of storing and querying measurement data Pending 09-May-2025
WO-2026234231-A1 Method of storing and querying measurement data Pending 09-May-2025
WO-2026233508-A1 Method for determining a minimum inhibitory concentration, and analysis method Pending 07-May-2025
To view Bruker’s complete patent history, request access »

Bruker Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bruker Investments & Acquisitions (113)

Bruker’s most recent deal was a Later Stage VC with Atinary. The deal was made on 14-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Atinary 14-Aug-2026 Later Stage VC Business/Productivity Software
MIMETAS 10-Aug-2026 Later Stage VC Discovery Tools (Healthcare)
Noscendo GmbH (DISQVER Clinical Metagenomics Platform) 15-Jul-2026 Corporate Asset Purchase Biotechnology
Tofwerk 06-Jan-2026 Merger/Acquisition Electronic Equipment and Instruments
Molzym 19-Nov-2025 Merger/Acquisition Diagnostic Equipment
You’re viewing 5 of 113 investments and acquisitions. Get the full list »

Bruker ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

23.31 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 67

Rank

Percentile

To view Bruker’s complete esg history, request access »

Bruker Exits (8)

Bruker’s most recent exit was on 12-Feb-2025 from Terrain Bio. The exit was categorized as with 9 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Terrain Bio 12-Feb-2025 Completed
  • 9 buyers
Tome Biosciences 12-Dec-2023 Completed
  • 8 buyers
Haystack Oncology 16-Nov-2022 Completed
  • 4 buyers
Ionpath 24-Sep-2020 Completed
  • 9 buyers
Bruker (ICP-MS Business) 19-May-2010 Merger/Acquisition Completed
You’re viewing 5 of 8 exits. Get the full list »

Bruker Affiliates

Subsidiaries (31)

Name Industry Location Year Founded
Acuity Spatial Genomics Santa Barbara, CA 2021
MIRO Analytical Wallisellen, Switzerland 2016
Canopy Biosciences Saint Louis, MO 2016
Zontal Billerica, MA 2016
Molecubes Gent, Belgium 2014
You’re viewing 5 of 31 affiliates. Get the full list.  »

Bruker FAQs

  • When was Bruker founded?

    Bruker was founded in 1960.

  • Where is Bruker headquartered?

    Bruker is headquartered in Billerica, MA.

  • What is the size of Bruker?

    Bruker has 11,085 total employees.

  • What industry is Bruker in?

    Bruker’s primary industry is Diagnostic Equipment.

  • Is Bruker a private or public company?

    Bruker is a Public company.

  • What is Bruker’s stock symbol?

    The ticker symbol for Bruker is BRKR.

  • What is the current stock price of Bruker?

    As of 20-Nov-2026 the stock price of Bruker is $56.47.

  • What is the current market cap of Bruker?

    The current market capitalization of Bruker is $8.62B.

  • What is Bruker’s current revenue?

    The trailing twelve month revenue for Bruker is $3.51B.

  • Who are Bruker’s competitors?

    Revvity, Sartorius, Sagence Technologies, GE HealthCare Technologies, and BioMérieux are some of the 14 competitors of Bruker.

  • What is Bruker’s annual earnings per share (EPS)?

    Bruker’s EPS for 12 months was -$1.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process